HMGB1 and rectal cancer: Our previous studies have demonstrated that the density and cytosolic pattern of HMGB1 (cyto-HMGB1) is an independent prognostic factor in locally advanced rectal cancer patients who underwent preoperative concurrent chemoradiotherapy, suggesting that chemoradiotherapy elicits the release of HMGB1 to promote ICD and antitumor immunity26.